Polyethylene glycol modified-albumin enhances the cold preservation properties of University of Wisconsin solution in rat liver and a hepatocyte cell line.
Liver grafts preserved in cold storage undergo changes mainly manifested by morphological modifications of the sinusoidal endothelium that result in poor graft function upon reperfusion. The present studies aimed to determine if the addition of polyethylene glycol-albumin to University of Wisconsin (Peg-AlbUW) solution ameliorates the cold preservation injuries of liver grafts. Rat livers were preserved cold with various preservation solutions and evaluated for weight changes and endothelial morphology. Solutions that preserved graft weight and endothelial morphology were tested in the isolated perfused rat liver model to assess graft function. A rat hepatocyte cell line was evaluated for both viability and glutathione concentrations emulating cold preservation and reperfusion conditions. Liver grafts preserved with Peg-AlbUW maintained their initial weight and showed a conserved endothelial morphology compared with liver grafts preserved in UW for 30 h (P<0.05). Liver grafts preserved with Peg-AlbUW had improved portal blood flow and bile secretion compared with liver grafts preserved in UW for 30 h (P<0.05). In vitro we noted comparable hepatocyte viability when cells were preserved in Peg-AlbUW versus UW under similar preservation conditions (P>0.05); glutathione concentrations (reduced and total) were significantly increased in hepatocytes preserved in 3% Peg-AlbUW compared with other preservation solutions (P<0.05). The addition of Peg-Alb to UW preservation solution ameliorated the cold preservation injuries of rat liver grafts as shown by stable liver graft weight, a better preservation of the endothelial morphology, improved portal vein blood flow, and increased bile secretion. Peg-Alb-UW solution improved the integrity of the glutathione redox buffer system of a hepatocyte cell line after cold storage and reperfusion.
Abbas
Rime
R
Department of Surgery, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-5047, USA.
Kombu
Rajan S
RS
Dignam
David
D
Gunning
William
W
Stulberg
Jonah J
JJ
Brunengraber
Henri
H
Sanabria
Juan R
JR
D000241:Adenosine / Q000494:pharmacology; D000418:Albumins / Q000494:pharmacology*; D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D017209:Apoptosis / Q000502:physiology; D002460:Cell Line; D015925:Cryopreservation / Q000379:methods; D042783:Endothelial Cells / Q000166:cytology / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism / Q000494:pharmacology; D006085:Graft Survival / Q000502:physiology; D022781:Hepatocytes / Q000166:cytology* / Q000378:metabolism; D007328:Insulin / Q000494:pharmacology; D007511:Ischemia / Q000378:metabolism; D016031:Liver Transplantation; D008297:Male; D009926:Organ Preservation / Q000379:methods*; D019188:Organ Preservation Solutions / Q000494:pharmacology*; D009929:Organ Size; D018384:Oxidative Stress / Q000187:drug effects; D011092:Polyethylene Glycols / Q000494:pharmacology*; D011887:Raffinose / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar
D000418:Albumins; D007328:Insulin; D019188:Organ Preservation Solutions; C055206:University of Wisconsin-lactobionate solution; D011092:Polyethylene Glycols; D000493:Allopurinol; D005978:Glutathione; D000241:Adenosine; D011887:Raffinose